Ledsaak Marit, Bengtsen Mads, Molværsmyr Ann-Kristin, Fuglerud Bettina Maria, Matre Vilborg, Eskeland Ragnhild, Gabrielsen Odd Stokke
Department of Biosciences, University of Oslo, P.O. Box 1066 Blindern, N-0316 Oslo, Norway.
Biochim Biophys Acta. 2016 May;1859(5):705-18. doi: 10.1016/j.bbagrm.2016.03.011. Epub 2016 Mar 29.
The PIAS proteins (Protein Inhibitor of Activated STATs) constitute a family of multifunctional nuclear proteins operating as SUMO E3 ligases and being involved in a multitude of interactions. They participate in a range of biological processes, also beyond their well-established role in the immune system and cytokine signalling. They act both as transcriptional corepressors and coactivators depending on the context. In the present work, we investigated mechanisms by which PIAS1 causes activation or repression of c-Myb dependent target genes. Analysis of global expression data shows that c-Myb and PIAS1 knockdowns affect a subset of common targets, but with a dual outcome consistent with a role of PIAS1 as either a corepressor or coactivator. Our mechanistic studies show that PIAS1 engages in a novel interaction with the acetyltransferase and coactivator p300. Interaction and ChIP analysis suggest a bridging function where PIAS1 enhances p300 recruitment to c-Myb-bound sites through interaction with both proteins. In addition, the E3 activity of PIAS1 enhances further its coactivation. Remarkably, the SUMO status of c-Myb had a decisive role, indicating a SUMO-dependent switch in the way PIAS1 affects c-Myb, either as a coactivator or corepressor. Removal of the two major SUMO-conjugation sites in c-Myb (2KR mutant), which enhances its activity significantly, turned PIAS1 into a corepressor. Also, p300 was less efficiently recruited to chromatin by c-Myb-2KR. We propose that PIAS1 acts as a "protein inhibitor of activated c-Myb" in the absence of SUMOylation while, in its presence, PIAS behaves as a "protein activator of repressed c-Myb".
PIAS蛋白(活化STAT蛋白的蛋白抑制剂)构成了一个多功能核蛋白家族,作为SUMO E3连接酶发挥作用,并参与多种相互作用。它们参与一系列生物过程,其作用范围超出了在免疫系统和细胞因子信号传导中已明确的作用。根据具体情况,它们既可以作为转录共抑制因子,也可以作为共激活因子发挥作用。在本研究中,我们探究了PIAS1激活或抑制c-Myb依赖性靶基因的机制。对全局表达数据的分析表明,c-Myb和PIAS1基因敲低会影响一部分共同靶点,但产生的双重结果与PIAS1作为共抑制因子或共激活因子的作用一致。我们的机制研究表明,PIAS1与乙酰转移酶和共激活因子p300发生了一种新的相互作用。相互作用和染色质免疫沉淀分析表明PIAS1具有一种桥梁功能,即通过与这两种蛋白相互作用,增强p300募集到与c-Myb结合的位点。此外,PIAS1的E3活性进一步增强了其共激活作用。值得注意的是,c-Myb的SUMO状态起着决定性作用,这表明PIAS1以共激活因子或共抑制因子影响c-Myb的方式存在SUMO依赖性转换。去除c-Myb中的两个主要SUMO共轭位点(2KR突变体)可显著增强其活性,这使得PIAS1变成了一个共抑制因子。同样,c-Myb-2KR将p300募集到染色质的效率较低。我们提出,在没有SUMO化的情况下,PIAS1作为“活化c-Myb的蛋白抑制剂”发挥作用,而在有SUMO化的情况下,PIAS则作为“受抑制c-Myb的蛋白激活剂”发挥作用。